PI3K: a potential therapeutic target for cancer.

@article{Chen2012PI3KAP,
  title={PI3K: a potential therapeutic target for cancer.},
  author={Yingwei Chen and Bao-can Wang and Yongtao Xiao},
  journal={Journal of cellular physiology},
  year={2012},
  volume={227 7},
  pages={2818-21}
}
Phosphatidylinositol 3-kinase (PI3K), one member of lipid kinase family, has been demonstrated to play a key role in regulating cell proliferation, adhesion, survival, and motility. Recent studies indicate that PI3K related signaling pathway is one of the most commonly activated pathways in human cancers. Accordingly, pharmacological inhibition of key nodes in this signaling cascade has been a focus in developmental therapeutics. To date, Inhibitors targeting PI3K or nodes in this pathway, AKT… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 20 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 39 references

CD 151 amplifies signaling by integrin alpha 6 beta 1 to PI 3 K and induces the epithelialmesenchymal transition in HCC cells

  • AL Kennedy, JP Morton, +8 authors PD Adams
  • Gastroenterology
  • 2011
Highly Influential
8 Excerpts

Activation of the PIK 3 CA / AKT pathway suppresses senescence induced by an activated RAS oncogene to promote tumorigenesis

  • KanzawaT KondoY, SawayaR, S Kondo
  • Mol Cell
  • 2011

Newphosphatidylinositol 3 - kinase inhibitors for cancer

  • LC Cantley
  • Expert Opin Invest Drugs
  • 2011

PI 3 Kgamma mediates kaposi ’ s sarcomaassociated herpesvirus vGPCRinduced sarcomagenesis

  • AK Murugan, NT Hong, Y Fukui, AK Munirajan, N Tsuchida
  • Cancer Cell
  • 2011

Structure of lipid kinase p 110 beta / p 85 beta elucidates an unusual SH 2domainmediated inhibitory mechanism

  • TT Zhao, D Trinh, CL Addison, J Dimitroulakos
  • Mol Cell
  • 2011

p 28 ( GANK ) overexpression accelerates hepatocellular carcinoma invasiveness and metastasis via phosphoinositol 3 - kinase / AKT / hypoxiainducible factor - 1 alpha pathways

  • GL Gallia, V Rand, +10 authors GJ Riggins
  • Hepatology
  • 2011

Similar Papers

Loading similar papers…